Calliditas Therapeutics AB Quarterly Assets in SEK from Q4 2019 to Q4 2023

Taxonomy & unit: ifrs-full: SEK
Summary: Calliditas Therapeutics AB quarterly Assets history and growth rate from Q4 2019 to Q4 2023.
Calliditas Therapeutics AB Assets for the quarter ending December 31, 2023 was 1.86B SEK, a 4.8% decline year-over-year.

Assets, Quarterly (SEK)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	1.86B	-93.7M	-4.8%	Dec 31, 2023	20-F	2024-04-24
Q2 2023	1.71B	+251M	+17.2%	Jun 30, 2023	6-K	2023-08-17
Q4 2022	1.95B	+493M	+33.8%	Dec 31, 2022	20-F	2024-04-24
Q2 2022	1.46B	+270M	+22.7%	Jun 30, 2022	6-K	2023-08-17
Q1 2022	1.34B	+1M	+0.08%	Mar 31, 2022	6-K	2022-05-20
Q4 2021	1.46B	-4M	-0.27%	Dec 31, 2021	20-F	2023-04-26
Q2 2021	1.19B	-298M	-20.1%	Jun 30, 2021	6-K	2022-08-19
Q1 2021	1.34B			Mar 31, 2021	6-K	2022-05-20
Q4 2020	1.46B	+619M	+73.2%	Dec 31, 2020	20-F	2022-04-27
Q2 2020	1.49B			Jun 30, 2020	6-K	2021-08-20
Q4 2019	845M			Dec 31, 2019	20-F/A	2022-01-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.